Clinical Trials Logo
  1. Home
  2. Gynecologic Cancer
  3. NCT05733806
  4. Details
NCT05733806 Clinical Trial

Study on Gynecological Rare Cancers

Gynecologic Cancer Clinical Trial

— MITO9B  

Official title:
Prospective, Multicenter, Observational Study on Rare Gynecological Cancers

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05733806
Other study ID # MITO 9B
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 14, 2019
Est. completion date February 1, 2030

Study information
Verified date February 2023
Source National Cancer Institute, Naples
Contact Francesco Perrone, MD
Phone 0039 081 1777 0276
Email f.perrone@istitutotumori.na.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a prospective, observational, multicenter study on gynecological rare tumors.

Description:

This is a prospective registry aimed to better understand prognosis, clinical and pathological features, management of this rare cancer conditions for improving standard of care.

Recruitment information / eligibility
Status Recruiting
Enrollment 500
Est. completion date February 1, 2030
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - rare gynecological malignancies - written informed consent - patient fit for follow-up Exclusion criteria -written informed consent not provided

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• chemotherapy, surgery
this is an observational prospective study, therefore no intervention is planned. Patients perform medical and surgical treatment as per standard of case.

Locations
Country Name City State
Italy Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele Milan
Italy IRCCS Fondazione G Pascale Naples

Sponsors (1)
Lead Sponsor Collaborator
National Cancer Institute, Naples

Country where clinical trial is conducted

Italy, 

Outcome
Type Measure Description Time frame Safety issue
Primary Prevalence of gynecologic rare malignancies To describe the prevalence of gynecologic rare tumors 5 years
See also
  Status Clinical Trial Phase
Completed NCT04890327 - Web-based Family History Tool N/A
Not yet recruiting NCT05467319 - Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS Phase 3
Recruiting NCT05478876 - Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract N/A
Active, not recruiting NCT04899492 - Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery N/A
Terminated NCT03658109 - Lidocaine Infusion or Quadratus Lumborum Block and Intrathecal Morphine, Versus Intrathecal Morphine Alone Early Phase 1
Recruiting NCT05296512 - Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer Phase 2
Not yet recruiting NCT06398314 - Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors N/A
Completed NCT01679483 - Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer N/A
Completed NCT01444924 - Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery Phase 2
Recruiting NCT05053230 - A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer N/A
Recruiting NCT04534075 - Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial Phase 3
Active, not recruiting NCT04584957 - Prophylactic Negative Pressure Wound Therapy (VAC) in Gynecologic Oncology (G.O.) N/A
Completed NCT03292328 - Yoga for Symptoms of Nerve Damage Caused by Chemotherapy N/A
Completed NCT02459301 - A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies Phase 1
Completed NCT05131490 - Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients N/A
Active, not recruiting NCT03899376 - A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT N/A
Not yet recruiting NCT05407987 - Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery) Phase 3
Recruiting NCT05891470 - To Explore the Benefits of the MonaLisa Touch® System in Gynaecological Cancer Patients Treated by (Chemo)-RT N/A
Not yet recruiting NCT05974995 - Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer N/A
Withdrawn NCT04368130 - SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care N/A